| NHLH2 |
NHLH2, HEN2: Helix-loop-helix protein 2 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
0.52 |
Evidence |
|
| PAX5 |
PAX5: Paired box protein Pax-5 |
KLF5 |
KLF5, BTEB2, CKLF, IKLF: Krueppel-like factor 5 |
0.52 |
Evidence |
|
| FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
0.52 |
Evidence |
|
| SYT1 |
SYT1, SVP65, SYT: Synaptotagmin-1 |
PDLIM5 |
PDLIM5, ENH: PDZ and LIM domain protein 5 |
0.52 |
Evidence |
|
| ELK1 |
ELK1: ETS domain-containing protein Elk-1 |
PAX5 |
PAX5: Paired box protein Pax-5 |
0.52 |
Evidence |
|
| EGR1 |
EGR1, ZNF225: Early growth response protein 1 |
PAX5 |
PAX5: Paired box protein Pax-5 |
0.52 |
Evidence |
|
| FOSL1 |
FOSL1, FRA1: Fos-related antigen 1 |
PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
0.52 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
KHDRBS3 |
KHDRBS3, SALP, SLM2: KH domain-containing, RNA-binding, signal transduction-asso |
0.52 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.52 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
TERF2IP |
TERF2IP, RAP1, PP8000: Telomeric repeat-binding factor 2-interacting protein 1 |
0.52 |
Evidence |
|
| MS4A1 |
MS4A1, CD20: B-lymphocyte antigen CD20 |
STX1A |
STX1A, STX1: Syntaxin-1A |
0.52 |
Evidence |
|
| ESRRA |
ESRRA, ERR1, ESRL1, NR3B1: Steroid hormone receptor ERR1 |
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
0.52 |
Evidence |
|
| CLEC3B |
CLEC3B, TNA: Tetranectin precursor |
CRKL |
CRKL: Crk-like protein |
0.52 |
Evidence |
|
| NR3C1 |
NR3C1, GRL: Glucocorticoid receptor |
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
0.52 |
Evidence |
|
| TGFB1 |
TGFB1, TGFB: Transforming growth factor beta-1 precursor |
PEA15 |
PEA15: Astrocytic phosphoprotein PEA-15 |
0.52 |
Evidence |
|
| SNRPD2 |
SNRPD2, SNRPD1: Small nuclear ribonucleoprotein Sm D2 |
GTF3C1 |
IPI00414481 |
0.52 |
Evidence |
|
| SNRPG |
SNRPG, PBSCG: Small nuclear ribonucleoprotein G |
GTF3C1 |
IPI00414481 |
0.52 |
Evidence |
|
| PSMA6 |
PSMA6, PROS27: Proteasome subunit alpha type-6 |
USP21 |
USP21, USP23: Ubiquitin carboxyl-terminal hydrolase 21 |
0.52 |
Evidence |
|
| MCM7 |
MCM7, CDC47, MCM2: DNA replication licensing factor MCM7 |
MAP2K3 |
MAP2K3, MEK3, MKK3, PRKMK3: Dual specificity mitogen-activated protein kinase ki |
0.52 |
Evidence |
|
| SSTR2 |
SSTR2: Somatostatin receptor type 2 |
PCDHGB4 |
IPI00028619 |
0.52 |
Evidence |
|
| HTR2A |
HTR2A, HTR2: 5-hydroxytryptamine receptor 2A |
PCDHGB4 |
IPI00028619 |
0.52 |
Evidence |
|
| PSMA4 |
PSMA4, PSC9: Proteasome subunit alpha type-4 |
USP21 |
USP21, USP23: Ubiquitin carboxyl-terminal hydrolase 21 |
0.52 |
Evidence |
|
| MBD3 |
MBD3: Methyl-CpG-binding domain protein 3 |
HIF1AN |
HIF1AN, FIH1: Hypoxia-inducible factor 1 alpha inhibitor |
0.52 |
Evidence |
|
| PSMA7 |
PSMA7: Proteasome subunit alpha type-7 |
S100A9 |
S100A9, CAGB, CFAG, MRP14: Protein S100-A9 |
0.52 |
Evidence |
|
| BNC1 |
BNC1, BNC: Zinc finger protein basonuclin-1 |
STK4 |
STK4, MST1: Serine/threonine-protein kinase 4 |
0.517 |
Evidence |
|